Search Results - "Derman BA"

Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

Authors: Sperling AS Derman BA Nikiforow S et al.

Source: Science translational medicine [Sci Transl Med] 2026 May 27; Vol. 18 (851), pp. eadx1799. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.

Authors: Susanibar-Adaniya S Derman BA Cohen AD et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Apr 28; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 28.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

The role of maintenance therapy and its cessation in patients with multiple myeloma.

Authors: Sneider AP Derman BA

Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (13), pp. 2426-2436. Date of Electronic Publication: 2025 Aug 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant.

Authors: Derman BA Cooperrider J Pula A et al.

Source: HemaSphere [Hemasphere] 2025 Aug 19; Vol. 9 (8), pp. e70186. Date of Electronic Publication: 2025 Aug 19 (Print Publication: 2025).

Publication Type: Letter

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Authors: Landgren O Biran N O'Donnell EK et al.

Source: HemaSphere [Hemasphere] 2025 Jul 16; Vol. 9 (7), pp. e70178. Date of Electronic Publication: 2025 Jul 16 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Remote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic Malignancies.

Authors: Derman BA Essell JH Ascha MS et al.

Source: JCO oncology practice [JCO Oncol Pract] 2026 Apr 10, pp. OP2501188. Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Authors: Alsina M Shah N Jagannath S et al.

Source: Cancer immunology research [Cancer Immunol Res] 2026 Apr 02; Vol. 14 (4), pp. 528-542.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.

Authors: Hicks LK Messersmith HJ Al Hadidi S et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Apr; Vol. 44 (10), pp. 914-941. Date of Electronic Publication: 2026 Jan 06.

Publication Type: Journal Article; Practice Guideline; Systematic Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Authors: Dytfeld D Wróbel T Jamroziak K et al.

Source: The Lancet. Haematology [Lancet Haematol] 2026 Apr; Vol. 13 (4), pp. e241-e253. Date of Electronic Publication: 2026 Mar 11.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Equivalence Trial; Comparative Study

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement.

Authors: D'Angelo CR Derman BA Devarakonda S et al.

Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Mar 09; Vol. 24 (5). Date of Electronic Publication: 2026 Mar 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.

Authors: Morgan HT Derman BA Ma H et al.

Source: Frontiers in immunology [Front Immunol] 2025 Apr 08; Vol. 16, pp. 1558275. Date of Electronic Publication: 2025 Apr 08 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma.

Authors: Grischke TK Cooperrider JH Pula A et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Mar 28; Vol. 15 (1), pp. 47. Date of Electronic Publication: 2025 Mar 28.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System.

Authors: Barnidge D Sakrikar D Kubicki T et al.

Source: The journal of applied laboratory medicine [J Appl Lab Med] 2025 Mar 03; Vol. 10 (2), pp. 235-249.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print Cited Medium: Print ISSN: 2576-9456 (Print) Linking ISSN: 24757241 NLM ISO Abbreviation: J Appl Lab Med Subsets: MEDLINE

Clinical applications of mass spectrometry in multiple myeloma.

Authors: Derman BA Yee AJ

Source: Blood advances [Blood Adv] 2025 Dec 23; Vol. 9 (24), pp. 6593-6603.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Can I stop my treatment, doctor? Is MRD-guided therapy ready for prime time?

Authors: Derman BA; Section of Hematology/Oncology, University of Chicago, Chicago, IL.

Source: Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2025 Dec 05; Vol. 2025 (1), pp. 645-651.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet ISSN: 1520-4383 (Electronic) Linking ISSN: 15204383 NLM ISO Abbreviation: Hematology Am Soc Hematol Educ Program Subsets: MEDLINE

Improving Access to T-Cell Therapies in Multiple Myeloma.

Authors: Derman BA; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL. Electronic address: bderman@bsd.uchicago.edu.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Nov; Vol. 24 (11), pp. 759-761. Date of Electronic Publication: 2024 Jul 03.

Publication Type: Editorial

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE; In Process

Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myeloma.

Authors: Marable M Kelly K Cooperrider JH et al.

Source: EJHaem [EJHaem] 2024 Oct 20; Vol. 5 (6), pp. 1260-1264. Date of Electronic Publication: 2024 Oct 20 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).

Authors: Derman BA Major A Cooperrider J et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Oct 07; Vol. 14 (1), pp. 170. Date of Electronic Publication: 2024 Oct 07.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication.

Authors: Padmaraju K Kelly K Jakubowiak AJ et al.

Source: The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. 806-810.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Chimeric Antigen Receptor T-Cell Therapy in Dialysis-Dependent Patients With Multiple Myeloma: Insights From a 5-Case Series.

Authors: Swamy V Kelly K Koyner JL et al.

Source: Kidney medicine [Kidney Med] 2025 Oct 10; Vol. 7 (12), pp. 101141. Date of Electronic Publication: 2025 Oct 10 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101756300 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0595 (Electronic) Linking ISSN: 25900595 NLM ISO Abbreviation: Kidney Med Subsets: PubMed not MEDLINE